These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20687892)

  • 1. The role of nuclear factor-kappaB in inflammatory lung disease.
    Imanifooladi AA; Yazdani S; Nourani MR
    Inflamm Allergy Drug Targets; 2010 Jul; 9(3):197-205. PubMed ID: 20687892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy.
    Wright JG; Christman JW
    Am J Respir Med; 2003; 2(3):211-9. PubMed ID: 14720003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappa B and its role in inflammatory lung disease.
    Alharbi KS; Fuloria NK; Fuloria S; Rahman SB; Al-Malki WH; Javed Shaikh MA; Thangavelu L; Singh SK; Rama Raju Allam VS; Jha NK; Chellappan DK; Dua K; Gupta G
    Chem Biol Interact; 2021 Aug; 345():109568. PubMed ID: 34181887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases.
    Alharbi KS; Afzal O; Almalki WH; Kazmi I; Javed Shaikh MA; Thangavelu L; Gulati M; Singh SK; Jha NK; Gupta PK; Chellappan DK; Oliver BG; Dua K; Gupta G
    Chem Biol Interact; 2022 Feb; 354():109842. PubMed ID: 35104489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of NF-kappaB in immune and inflammatory responses in the gut.
    Neurath MF; Becker C; Barbulescu K
    Gut; 1998 Dec; 43(6):856-60. PubMed ID: 9824616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchial asthma, chronic obstructive pulmonary disease and NF-kappaB.
    Charokopos N; Apostolopoulos N; Kalapodi M; Leotsinidis M; Karamanos N; Mouzaki A
    Curr Med Chem; 2009; 16(7):867-83. PubMed ID: 19275599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-κB: a key regulator in health and disease of lungs.
    Batra S; Balamayooran G; Sahoo MK
    Arch Immunol Ther Exp (Warsz); 2011 Oct; 59(5):335-51. PubMed ID: 21786215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
    Uwe S
    Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription Factor NF-κB: An Update on Intervention Strategies.
    Panday A; Inda ME; Bagam P; Sahoo MK; Osorio D; Batra S
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(6):463-483. PubMed ID: 27236331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB regulation in the immune system.
    Li Q; Verma IM
    Nat Rev Immunol; 2002 Oct; 2(10):725-34. PubMed ID: 12360211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A20 regulation of nuclear factor-κB: perspectives for inflammatory lung disease.
    Kelly C; Shields MD; Elborn JS; Schock BC
    Am J Respir Cell Mol Biol; 2011 Jun; 44(6):743-8. PubMed ID: 21239605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.
    Edwards MR; Bartlett NW; Clarke D; Birrell M; Belvisi M; Johnston SL
    Pharmacol Ther; 2009 Jan; 121(1):1-13. PubMed ID: 18950657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation?
    Haddad JJ; Abdel-Karim NE
    Cell Immunol; 2011; 271(1):5-14. PubMed ID: 21777910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB as a therapeutic target in chronic inflammation: recent advances.
    Makarov SS
    Mol Med Today; 2000 Nov; 6(11):441-8. PubMed ID: 11074370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NF-kappaB in endotoxemia-induced alterations of lung neutrophil apoptosis.
    Kupfner JG; Arcaroli JJ; Yum HK; Nadler SG; Yang KY; Abraham E
    J Immunol; 2001 Dec; 167(12):7044-51. PubMed ID: 11739525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway.
    Patel H; McIntire J; Ryan S; Dunah A; Loring R
    J Neuroinflammation; 2017 Sep; 14(1):192. PubMed ID: 28950908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The non-canonical NF-κB pathway in immunity and inflammation.
    Sun SC
    Nat Rev Immunol; 2017 Sep; 17(9):545-558. PubMed ID: 28580957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation.
    Tornatore L; Thotakura AK; Bennett J; Moretti M; Franzoso G
    Trends Cell Biol; 2012 Nov; 22(11):557-66. PubMed ID: 22995730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models.
    Lixuan Z; Jingcheng D; Wenqin Y; Jianhua H; Baojun L; Xiaotao F
    Pulm Pharmacol Ther; 2010 Oct; 23(5):411-9. PubMed ID: 20566376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and Atherosclerosis.
    Yu XH; Zheng XL; Tang CK
    Adv Clin Chem; 2015; 70():1-30. PubMed ID: 26231484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.